Regenerative Biotechnology
Gencell® CTM Inmunoboost
Immunomodulatory cellular combination with MSCs and memory Natural Killer cells.
Injectable solution combining melatonin-pretreated mesenchymal stem cells and allogeneic memory Natural Killer cells for immune reinforcement and controlled tissue repair.
Composition
CTM pretreated with melatonin and allogeneic NK cells.
Pharmaceutical form
Injectable solution.
Presentation
Single-dose vial, 4 ml.
Therapeutic properties
Immunomodulatory and regenerative action through MSC and memory NK cell synergy, promoting tissue repair and efficient immune response.
- Immune response enhancement.
- Reduction of systemic inflammation.
- Elimination of infected cells.
- Support in severe viral infections.
- Apoyo en infecciones bacterianas severas.
- Repair of damaged tissues.
- Regulation of immunosuppressed states.
- Improvement of intercellular communication.
Mechanism of action & Clinical data
Las CTM migran y modulan inflamación y regeneración tisular; las NK de memoria inducen apoptosis de células infectadas mediante perforinas, granzimas y liberación de citocinas.
Indications
Coadyuvante en inmunosupresión, infecciones virales y bacterianas severas, infecciones crónicas, sepsis y enfermedades autoinmunes.
Administration
Intravenous administration via slow infusion diluted in 0.9% saline solution using a Y-connector. Do not administer as bolus.
Contraindications
Hypersensitivity or allergy to any component of the formula. Diagnosis of neoplasia.
Storage
Store refrigerated between 2–8 °C, protected from direct sunlight. Avoid freezing and shaking.
